BRNS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.0256, suggesting BRNS is Strong Sell.

Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.701, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it Sell.

Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.717, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it Sell.

Technical Analysis for BRNS

Technical Sentiment Analysis for Barinthus Biotherapeutics PLC (BRNS) As of 2026-02-18, Barinthus Biotherapeutics PLC (BRNS) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 4 indicators are flashing buy, while 8 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for BRNS stands at 42.46, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0256, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 39.123 and the Commodity Channel Index (CCI) at -122.348 further confirm a -0.085 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, BRNS is trading below its 60-day moving average of $0.717 and below its 200-day long-term moving average of $1.018. Key price levels to watch include the immediate resistance at $0.764 and strong support at $0.574. A break above $0.764 could signal a bull continuation, while falling below $0.574 may test the next Fibonacci floor at $0.472.

Barinthus Biotherapeutics PLC (BRNS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.384	0.472	0.574	0.662	0.764	0.852	0.954
Fibonacci	0.472	0.544	0.589	0.662	0.734	0.779	0.852

Barinthus Biotherapeutics PLC (BRNS) Technical Indicators

2026-02-18

Name	Value
RSI_14	42.46
STOCHk_14_3_3	39.123
STOCHd_14_3_3	37.848
CCI_20	-122.348
AO_5_34	-0.0688
MOM_10	-0.085
MACD_12_26_9	-0.0256

Barinthus Biotherapeutics PLC (BRNS) Relative Strength Index (RSI) is 42.46, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Stochastic Oscillator is 39.123, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Stochastic RSI is 37.848, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Commodity Channel Index (CCI) is -122.348, creating a Buy signal.

Barinthus Biotherapeutics PLC (BRNS) Awesome Oscillator is -0.0688, creating a Sell signal.

Barinthus Biotherapeutics PLC (BRNS) Momentum is -0.085, creating a Sell signal.

Barinthus Biotherapeutics PLC (BRNS) MACD is -0.0256, creating a Sell signal.

Barinthus Biotherapeutics PLC (BRNS) Moving Average

2026-02-18

Period	Simple	Signal
MA_5	0.638	Buy
MA_10	0.675	Sell
MA_20	0.701	Sell
MA_60	0.717	Sell
MA_200	1.018	Sell
MA_250	0.997	Sell

Barinthus Biotherapeutics PLC (BRNS) 5-Day simple moving average is 0.638, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 10-Day simple moving average is 0.675, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.701, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.717, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 200-Day simple moving average is 1.018, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 250-Day simple moving average is 0.997, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.66, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for BRNS?

The overall technical consensus for Barinthus Biotherapeutics PLC (BRNS) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 3 sell signals.

What are the key support and resistance levels for Barinthus Biotherapeutics PLC (BRNS) today?

Based on pivot point calculations, Barinthus Biotherapeutics PLC (BRNS) has an immediate support level at 0.574 and a major resistance level at 0.764. Traders also monitor the pivot point at 0.662 to determine the intraday trend direction.

Is Barinthus Biotherapeutics PLC (BRNS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Barinthus Biotherapeutics PLC (BRNS) is currently 42.46. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Barinthus Biotherapeutics PLC (BRNS)?

Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.0256, suggesting BRNS is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Barinthus Biotherapeutics PLC.

How is Barinthus Biotherapeutics PLC (BRNS) performing relative to its 200-day moving average?

Barinthus Biotherapeutics PLC (BRNS) is currently trading at $0.66, which is below its 200-day simple moving average of 1.018. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.